Search

This study provides a comprehensive list of Turkey aphid fauna (Hemiptera: Aphididea). A total of 466 species and 12 subspecies belonging to 141 genera and 13 tribes, are listed. The list includes all records from 1903 to 2011. The family of Aphididae comprise the highest number of species (457), followed by Adelgidae (6) and Phylloxeridae (3), respectively. Inside Aphididae, the tribe of Macrosiphini is the richest group with 197 species, whereas the tribe of Cinarini has only one species. The number of aphid species actually reported for Turkey is lower than recorded for neighboring countries, suggesting that further faunistic studies needs to improve informations on this topic.

a result of the study carried out between 2007 and 2009 in the eastern part of the Black Sea Region of Turkey, 4 genera and 17 species were determined as new records for the Turkish aphid fauna. New recorded species are Aphis arbuti, Aphis cytisorum, Aphis kachkoulii, Cavariella digitata, Chaitophorus kapuri, Chaitophorus longisetosus, Cinara pinivora, Illinoia lambersi, Myzus beybienkoi, Neobetulaphis pusilla, Phyllaphis fagifoliae, Pseudessigella brachychaeta, Schizaphis rotundiventris, Symdobious oblongus, Thecabius lysimachiae, Thelaxes californica and Tinocallis takachihoensis. With these new records, the number of genera increased to 134 and the number of the species in the Turkish aphid fauna amounted to about 480. Since Turkey has a huge range of agricultural crops and a great diversity in its natural flora, research conducted on the Turkish aphid fauna has current and future indications for plant protection. [ABSTRACT FROM AUTHOR]

Background: Diffuse large B cell lymphoma is the most frequent aggressive non-Hodgkin lymphoma. Predicting response and estimating prognosis earlier makes management of this heterogeneous lymphoma more satisfying. Interim PET response is established in Hodgkin Lymphoma to tailor the therapy but results for non-Hodgkin Lymphoma is unconvincing. In the current study evaluation of interim PET and survival outcomes of 103 DLBCL patients is performed., Patients and Methods: About 103 Patients with DLBCL followed up in a single center between 2009 and 2019 were enrolled the study. All patients received R-CHOP chemoimmunotherapy at first line. Interim PET was performed after at least one or more cycles. All PET scans were performed with 18 F-FDG isotope as PET/CT. PET scoring results were evaluated according to the 5-Point Deauville Scoring system defined in the National Comprehensive Cancer Network clinical guidelines for iPET and eotPET. 5-P DS of scores of 1 to 3 were defined as negative scans, and scores of 4 to 5 were considered to be positive scans., Results: Forty-six (44.7%) Female and 57 (55.3%) male aged between 25 and 83 (median 57) years newly diagnosed DLBCL patients were enrolled in the study. Median PFS was 21 (interquartile range 8.5-53.7) months and median OS was 33.5 (interquartile range 12.5-62.9) months for the total cohort. Positive predictive value of interim PET according to Deauville scoring system was 65.4% and negative predictive value was 77.9%., Conclusion: Our study showed that according to Deauville 5 point scale (D 5PS) scoring system, interim PET-positive patients have shorter both PFS and OS than iPET-negative patients., (Copyright © 2021 Elsevier Ltd. All rights reserved.)

Introduction: Hodgkin lymphoma (HL) is unusual among malignancies, with inflammation playing such a prominent role in its pathogenesis. S100A8/A9 (calprotectin) is a heterodimeric protein, which has a role in the inflammatory response and oncogenesis. In this study in HL patients, the correlation between serum S100A8/A9 levels and treatment responses was investigated along with whether this marker is correlated with other inflammatory markers., Materials and Methods: Thirty-three HL patients and 20 healthy volunteers were included. Demographic and clinical characteristics were recorded. Calprotectin levels were measured with Human S100A8/A9 Heterodimer Quantikine ELISA kit. Calprotectin levels were measured twice in patients, before and after treatment, and once in the control group. Treatment responses were evaluated with positron emission tomography-computed tomography (PET-CT)., Results: The mean age of patients was 44.3 ± 18.1 (66.3% male). The median (IQR) values of S100A8/A9 before and after treatment in the patient group were 4.98 (2.6-7.8) and 1.87 (1.1-4.8)µg/mL. Median (IQR) S100A8/A9 concentration in the control group was 1.41 (0.98-2.73)µg/mL. In patients, pretreatment values were significantly higher than in controls (P < .001). However, median values of patients after treatment and controls were similar. Patient median S100A8/A9 levels were significantly lower post-treatment compared with pretreatment values (P = .001). When inflammatory markers were examined within groups, no relationship was found between markers. In ROC analysis, a S100A8/A9 cutoff value of ≥3.31µg/mL accurately discriminated end-of-treatment PET positivity (AUC = 0.78; 95% CI 0.58-0.98; accuracy = 76.2%)., Conclusion: S100A8/A9 may be a potential biomarker for treatment response in HL independent of inflammation. This is the first study to investigate and show this finding. However, further large-scale studies are still required., (© 2021 John Wiley & Sons Ltd.)

Recent studies showed the crucial role of different aspects of phenotypic plasticity when organisms exposed to various environments. Presented study tested integrations among the phenotypic plasticities in fitness, morphological features and host choice behavior of the Aphis fabae genotypes exposed to two different host plants. Results indicated that different aspects of phenotypic plasticities in black bean aphid were not systemically affected by host plant conditions as these features have independent regulation. Host plant conditions affected types of phenotypic plasticities in a different way. However, particularly plasticity in ultimate rostral segment positively integrated with plasticity in fitness on novel host plant.